ZENTEK LTD (ZEN.CA) Fundamental Analysis & Valuation
TSX-V:ZEN • CA98942X1024
Current stock price
0.83 CAD
-0.02 (-2.35%)
Last:
This ZEN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZEN.CA Profitability Analysis
1.1 Basic Checks
- ZEN had negative earnings in the past year.
- ZEN had a negative operating cash flow in the past year.
- In the past 5 years ZEN always reported negative net income.
- ZEN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- ZEN has a Return On Assets of -48.58%. This is in the better half of the industry: ZEN outperforms 73.33% of its industry peers.
- ZEN has a Return On Equity of -70.13%. This is in the better half of the industry: ZEN outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.58% | ||
| ROE | -70.13% | ||
| ROIC | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ZEN has a worse Gross Margin (48.67%) than 60.00% of its industry peers.
- ZEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ZEN.CA Health Analysis
2.1 Basic Checks
- ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ZEN has been increased compared to 1 year ago.
- ZEN has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ZEN has an improved debt to assets ratio.
2.2 Solvency
- ZEN has an Altman-Z score of 1.34. This is a bad value and indicates that ZEN is not financially healthy and even has some risk of bankruptcy.
- ZEN's Altman-Z score of 1.34 is amongst the best of the industry. ZEN outperforms 93.33% of its industry peers.
- A Debt/Equity ratio of 0.15 indicates that ZEN is not too dependend on debt financing.
- With an excellent Debt to Equity ratio value of 0.15, ZEN belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.34 |
ROIC/WACCN/A
WACC9.16%
2.3 Liquidity
- ZEN has a Current Ratio of 0.79. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
- ZEN has a Current ratio (0.79) which is comparable to the rest of the industry.
- ZEN has a Quick Ratio of 0.79. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.53, ZEN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.53 |
3. ZEN.CA Growth Analysis
3.1 Past
- ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.08%, which is quite impressive.
- The Revenue has grown by 2223.10% in the past year. This is a very strong growth!
- The Revenue has been growing by 35.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ZEN.CA Valuation Analysis
4.1 Price/Earnings Ratio
- ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. ZEN.CA Dividend Analysis
5.1 Amount
- ZEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ZEN.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:ZEN (3/13/2026, 7:00:00 PM)
0.83
-0.02 (-2.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17 2026-02-17
Earnings (Next)06-24 2026-06-24
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners0.83%
Ins Owner ChangeN/A
Market Cap89.24M
Revenue(TTM)915.30K
Net Income(TTM)-8.20M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 97.5 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 7.64 | ||
| P/tB | 7.64 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.01
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.58% | ||
| ROE | -70.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.67% | ||
| FCFM | N/A |
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 88.48% | ||
| Cap/Sales | 54.4% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 1.34 |
F-Score4
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.4%
OCF growth 3YN/A
OCF growth 5YN/A
ZENTEK LTD / ZEN.CA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ZENTEK LTD?
ChartMill assigns a fundamental rating of 2 / 10 to ZEN.CA.
What is the valuation status of ZENTEK LTD (ZEN.CA) stock?
ChartMill assigns a valuation rating of 0 / 10 to ZENTEK LTD (ZEN.CA). This can be considered as Overvalued.
Can you provide the profitability details for ZENTEK LTD?
ZENTEK LTD (ZEN.CA) has a profitability rating of 1 / 10.